Thermo Fisher Scientific (TMO) Tax Provisions (2009 - 2026)

Thermo Fisher Scientific has disclosed Tax Provisions across 18 years of filings, most recently posting $70.0 million for Q1 2026.

• Quarterly Tax Provisions fell 26.32% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $522.0 million (up 10.59% YoY) and the FY2025 annual result came in at $547.0 million, down 16.74% from the prior year.
• Tax Provisions retreated to $70.0 million in Q1 2026, from $153.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $301.0 million in Q2 2022 and troughed at $31.0 million in Q4 2022.
• A 5-year average of $133.1 million and a median of $128.0 million in 2024 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2022 — Tax Provisions plunged 88.56% — and 2024, when it jumped 510.87%.
• Tracing TMO's Tax Provisions over 5 years: stood at $173.0 million in 2022, then slipped by 23.12% to $133.0 million in 2023, then advanced by 12.78% to $150.0 million in 2024, then rose by 2.0% to $153.0 million in 2025, then sank by 54.25% to $70.0 million in 2026.
• Business Quant data shows TMO's Tax Provisions at $70.0 million in Q1 2026, $153.0 million in Q4 2025, and $207.0 million in Q3 2025.